Startups
46brooklyn Research is an Ohio non-profit corporation whose purpose is to improve the accessibility and usability of U.S. drug pricing data. 46brooklyn takes the myriad drug pricing data sources scattered across the web and stitches them together into data visualizations that can be used by the public to better understand how the drug supply chain functions. 46brooklyn also writes and publishes original research that uses the data within its public data visualizations to shine light on the hidden and complex underbelly of the drug supply chain.
At 46brooklyn, we believe the rampant complexity that is characteristic of how our drugs are priced is creating serious consequences for payers, patients, and providers across this country. Our purpose is to unlock the value buried in our country’s vast but disparate drug pricing databases to bring awareness to the nature and design of this complexity. Our hope is that better awareness and education will help improve the accountability of our supply chain and, in time, lead to the much-needed simplification of how drugs are priced.
46brooklyn Research (EIN #83-3213092) is an IRS-recognized 501(c)(3) Public Charity, and all monetary donations are tax deductible to the fullest extent allowed by tax laws. Please check with your financial advisor if you have more questions.
At 46brooklyn, we believe the rampant complexity that is characteristic of how our drugs are priced is creating serious consequences for payers, patients, and providers across this country. Our purpose is to unlock the value buried in our country’s vast but disparate drug pricing databases to bring awareness to the nature and design of this complexity. Our hope is that better awareness and education will help improve the accountability of our supply chain and, in time, lead to the much-needed simplification of how drugs are priced.
46brooklyn Research (EIN #83-3213092) is an IRS-recognized 501(c)(3) Public Charity, and all monetary donations are tax deductible to the fullest extent allowed by tax laws. Please check with your financial advisor if you have more questions.
Overview
Location
United States, Ohio, Dayton
Employees
11-50
Founded date
2018
Mentions in press and media 14
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 18, 2024 | Drugmakers hiking prices for more than 700 medications, including Ozempic and Mounjaro | Fighting rising prescription drug costs Fighting rising prescription drug costs 07:59 Pharmaceutical companies are hiking prices for more than 700 medications, including popular weight-loss drugs Ozempic and Mounjaro, industry research show... |
| Jul 15, 2022 | Manchin plays spoiler again, but drug pricing reforms remain on the table | West Virginia Democrat Sen. Joe Manchin has made loud and clear how much his single vote matters for the Senate Dems, and their even 50-50 split with Republicans, once again laying guardrails around a reconciliation package... |
| Jan 7, 2022 | Out-of-pocket drug costs for Medicare beneficiaries need to be reined in | This year, 56 million U.S. seniors will pay more for Medicare prescription drug coverage, partly due to a single drug most will not take — Aduhelm, a newly approved, expensive, and controversial Alzheimer’s drug. In late 2021, the Centers f... |
| Jan 4, 2022 | The big-ticket drugs that have higher prices in 2022 | Sign up for our daily briefingMake your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes. Enter your email address Please enter a valid email. Please enter a valid email. Subscription failedSub... |
| Sep 9, 2021 | The federal government closes in on healthcare pricing transparency—here’s what digital health players are doing about it | The news: The Biden administration is doubling down on drug pricing transparency with a new plan to lower drug prices. This will allow the CMS to negotiate drug prices, limit price increases, promote industry competition, and support medica... |
| Jan 5, 2021 | GLAXOSMITHKLINE PLC GlaxoSmithKline : Drugmakers kick off 2021 with 500 U.S. price hikes | The hikes come as drugmakers are reeling from effects of the COVID-19 pandemic, which has reduced doctor visits and demand for some drugs. They are also fighting new drug price-cutting rules from the Trump administration, which would reduce... |
| Jan 5, 2021 | GlaxoSmithKline : Drugmakers kick off 2021 with 500 U.S. price hikes | The hikes come as drugmakers are reeling from effects of the COVID-19 pandemic, which has reduced doctor visits and demand for some drugs. They are also fighting new drug price-cutting rules from the Trump administration, which would reduce... |
| Jan 5, 2021 | Pharma firms ring in 2021 by hiking prices for hundreds of drugs | More On: prescription drugs Detroit-area pharmacist busted for forging $2 million in fake prescriptions Doctor facing trial accused of asking Hells Angels to snuff witness Long Island dentist arrested in painkillers-for-sex scheme: feds Gro... |
| Jan 5, 2021 | Pharma firms ring in 2021 by hiking prices for hundreds of drugs | More On: prescription drugs Arkansas rapper Bankroll Freddie busted for drugs, gun House passes $35-a-month insulin cap as Dems seek wider bill Teens storm NYC pharmacies in grab-and-go prescription drug heists Startups push ADHD meds throu... |
Show more
Reviews 0
FAQ about 46brooklyn Research
When was 46brooklyn Research founded?
46brooklyn Research was founded in 2018.
What has the press written about 46brooklyn Research?
Parsers VC has collected 14 articles mentioning 46brooklyn Research, among them “Drugmakers hiking prices for more than 700 medications, including Ozempic and Mounjaro” (Jan 18, 2024) and “Manchin plays spoiler again, but drug pricing reforms remain on the table” (Jul 15, 2022).
Is 46brooklyn Research still active?
Yes, 46brooklyn Research is active; its latest activity on Parsers VC dates from Oct 2, 2026.